Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified. more
| Time Frame | IBBQ | S&P500 |
|---|---|---|
| 1-Week Return | -1.46% | 0.01% |
| 1-Month Return | 15.22% | 3.54% |
| 3-Month Return | 13.83% | 10.58% |
| 6-Month Return | 15.1% | 8.03% |
| 1-Year Return | 47.92% | 20.06% |
| 3-Year Return | 62.84% | 70.98% |
| 5-Year Return | 29.16% | 71.89% |
| 10-Year Return | 29.36% | 252.66% |
| Time Frame | IBBQ | S&P500 |
|---|---|---|
| 1-Week Return | -53.55% | 0.52% |
| 1-Month Return | 460.52% | 52.69% |
| 3-Month Return | 69.10% | 50.36% |
| 6-Month Return | 33.00% | 16.96% |
| 1-Year Return | 47.92% | 20.06% |
| 3-Year Return | 17.65% | 19.58% |
| 5-Year Return | 5.25% | 11.44% |
| 10-Year Return | 2.61% | 13.43% |
| Stock name | Ticker | Weight |
|---|---|---|
Vertex Pharmaceuticals Inc
|
VRTX |
7.83%
|
Amgen Inc
|
AMGN |
7.62%
|
Gilead Sciences Inc
|
GILD |
7.08%
|
Regeneron Pharmaceuticals Inc
|
REGN |
4.63%
|
Alnylam Pharmaceuticals Inc
|
ALNY |
2.81%
|
Revolution Medicines Inc
|
RVMD |
2.74%
|
Moderna Inc
|
MRNA |
2.04%
|
Biogen Inc
|
BIIB |
1.98%
|
Illumina Inc
|
ILMN |
1.97%
|
Roivant Sciences Ltd
|
ROIV |
1.78%
|
Royalty Pharma PLC
|
RPRX |
1.73%
|
Insmed Inc
|
INSM |
1.73%
|
Argenx SE
|
ARGX |
1.69%
|
Incyte Corp
|
INCY |
1.59%
|
United Therapeutics Corp
|
UTHR |
1.58%
|
Guardant Health Inc
|
GH |
1.46%
|
Viatris Inc
|
VTRS |
1.28%
|
Neurocrine Biosciences Inc
|
NBIX |
1.22%
|
Bridgebio Pharma Inc
|
BBIO |
1.19%
|
Ascendis Pharma A/S
|
ASND |
1.14%
|
Jazz Pharmaceuticals PLC
|
Jazz.Pharmaceuticals.PLC |
1.04%
|
Medpace Holdings Inc
|
MEDP |
1.03%
|
Exelixis Inc
|
EXEL |
0.97%
|
Madrigal Pharmaceuticals Inc
|
MDGL |
0.87%
|
Axsome Therapeutics Inc
|
AXSM |
0.86%
|
Summit Therapeutics Inc
|
SMMT |
0.81%
|
Arrowhead Pharmaceuticals Inc
|
ARWR |
0.8%
|
Cytokinetics Inc
|
CYTK |
0.79%
|
BioMarin Pharmaceutical Inc
|
BMRN |
0.78%
|
Krystal Biotech Inc
|
KRYS |
0.74%
|
BioNTech SE
|
BNTX |
0.73%
|
Tempus AI Inc
|
TEM |
0.72%
|
Ionis Pharmaceuticals Inc
|
IONS |
0.72%
|
Sanofi SA
|
SNY |
0.69%
|
BeOne Medicines Ltd
|
ONC |
0.67%
|
Kymera Therapeutics Inc
|
KYMR |
0.66%
|
Halozyme Therapeutics Inc
|
HALO |
0.63%
|
ImmunityBio Inc
|
IBRX |
0.63%
|
Praxis Precision Medicines Inc
|
PRAX |
0.63%
|
Nuvalent Inc
|
NUVL |
0.61%
|
Alkermes PLC
|
ALKS |
0.6%
|
Protagonist Therapeutics Inc
|
PTGX |
0.6%
|
Crinetics Pharmaceuticals Inc
|
CRNX |
0.59%
|
Vaxcyte Inc
|
PCVX |
0.58%
|
Spyre Therapeutics Inc
|
SYRE |
0.58%
|
Immunovant Inc
|
IMVT |
0.57%
|
Apogee Therapeutics Inc
|
APGE |
0.56%
|
Abivax SA
|
ABVX |
0.55%
|
Rhythm Pharmaceuticals Inc
|
RYTM |
0.53%
|
Mirum Pharmaceuticals Inc
|
MIRM |
0.52%
|
PTC Therapeutics Inc
|
PTCT |
0.5%
|
Scholar Rock Holding Corp
|
SRRK |
0.47%
|
Cogent Biosciences Inc
|
COGT |
0.47%
|
Xenon Pharmaceuticals Inc
|
XENE |
0.46%
|
CG oncology Inc
|
CGON |
0.44%
|
Ligand Pharmaceuticals Inc
|
LGND |
0.44%
|
Erasca Inc
|
ERAS |
0.4%
|
Twist Bioscience Corp
|
TWST |
0.39%
|
Travere Therapeutics Inc
|
TVTX |
0.37%
|
CRISPR Therapeutics AG
|
CRSP |
0.37%
|
Amneal Pharmaceuticals Inc
|
AMRX |
0.37%
|
Oruka Therapeutics Inc
|
ORKA |
0.36%
|
Definium Therapeutics Inc
|
DFTX |
0.35%
|
Edgewise Therapeutics Inc
|
EWTX |
0.35%
|
Caris Life Sciences Inc
|
CAI |
0.34%
|
Indivior Pharmaceuticals Inc
|
INDV |
0.34%
|
10X Genomics Inc
|
TXG |
0.34%
|
Veracyte Inc
|
VCYT |
0.32%
|
ACADIA Pharmaceuticals Inc
|
ACAD |
0.3%
|
Relay Therapeutics Inc
|
RLAY |
0.3%
|
Tango Therapeutics Inc
|
TNGX |
0.3%
|
Denali Therapeutics Inc
|
DNLI |
0.29%
|
Structure Therapeutics Inc
|
GPCR |
0.29%
|
Newamsterdam Pharma Co NV
|
Newamsterdam.Pharma.Co.NV |
0.28%
|
Dyne Therapeutics Inc
|
DYN |
0.27%
|
Alumis Inc
|
ALMS |
0.25%
|
Beam Therapeutics Inc
|
BEAM |
0.25%
|
Arcutis Biotherapeutics Inc
|
ARQT |
0.24%
|
Adaptive Biotechnologies Corp
|
ADPT |
0.23%
|
Ultragenyx Pharmaceutical Inc
|
RARE |
0.23%
|
Ideaya Biosciences Inc
|
IDYA |
0.22%
|
GRAIL Inc
|
GRAL |
0.22%
|
Enliven Therapeutics Inc
|
ELVN |
0.21%
|
MBX Biosciences Inc
|
MBX |
0.21%
|
Vera Therapeutics Inc
|
VERA |
0.2%
|
Kiniksa Pharmaceuticals International Plc
|
Kiniksa.Pharmaceuticals.International.Plc |
0.2%
|
Disc Medicine Inc
|
IRON |
0.2%
|
Supernus Pharmaceuticals Inc
|
SUPN |
0.19%
|
uniQure NV
|
uniQure.NV |
0.19%
|
Tarsus Pharmaceuticals Inc
|
TARS |
0.19%
|
BioCryst Pharmaceuticals Inc
|
BCRX |
0.18%
|
Trevi Therapeutics Inc
|
TRVI |
0.18%
|
Nurix Therapeutics Inc
|
NRIX |
0.17%
|
Agios Pharmaceuticals Inc
|
AGIO |
0.17%
|
Pharvaris NV
|
Pharvaris.NV |
0.17%
|
Kodiak Sciences Inc
|
KOD |
0.17%
|
Vericel Corp
|
VCEL |
0.17%
|
Mineralys Therapeutics Inc
|
MLYS |
0.16%
|
Legend Biotech Corp
|
LEGN |
0.15%
|
Ocular Therapeutix Inc
|
OCUL |
0.15%
|
Genmab A/S
|
GMAB |
0.15%
|
AbCellera Biologics Inc
|
ABCL |
0.15%
|
Harmony Biosciences Holdings Inc
|
HRMY |
0.15%
|
Syndax Pharmaceuticals Inc
|
SNDX |
0.15%
|
Sarepta Therapeutics Inc
|
SRPT |
0.15%
|
Intellia Therapeutics Inc
|
NTLA |
0.14%
|
ADMA Biologics Inc
|
ADMA |
0.14%
|
Aurinia Pharmaceuticals Inc
|
AUPH |
0.14%
|
Monte Rosa Therapeutics Inc
|
GLUE |
0.14%
|
Stoke Therapeutics Inc
|
STOK |
0.14%
|
Amylyx Pharmaceuticals Inc
|
AMLX |
0.14%
|
Sionna Therapeutics Inc
|
SION |
0.14%
|
Rapport Therapeutics Inc
|
RAPP |
0.13%
|
Novocure Ltd
|
NVCR |
0.13%
|
Zymeworks Inc
|
ZYME |
0.13%
|
Recursion Pharmaceuticals Inc
|
RXRX |
0.13%
|
Precigen Inc
|
PGEN |
0.13%
|
AtaiBeckley Inc
|
ATAI |
0.13%
|
Tyra Biosciences Inc
|
TYRA |
0.13%
|
UroGen Pharma Ltd
|
UroGen.Pharma.Ltd |
0.13%
|
Iovance Biotherapeutics Inc
|
IOVA |
0.13%
|
Bicara Therapeutics Inc
|
BCAX |
0.13%
|
AnaptysBio Inc
|
ANAB |
0.13%
|
ANI Pharmaceuticals Inc
|
ANIP |
0.13%
|
Taysha Gene Therapies Inc
|
TSHA |
0.13%
|
GH Research PLC
|
GHRS |
0.13%
|
Zenas Biopharma Inc
|
ZBIO |
0.12%
|
Compass Pathways Plc
|
CMPS |
0.12%
|
Maze Therapeutics Inc
|
MAZE |
0.12%
|
Absci Corp
|
ABSI |
0.12%
|
Vir Biotechnology Inc
|
VIR |
0.12%
|
Septerna Inc
|
SEPN |
0.11%
|
Fortrea Holdings Inc
|
FTRE |
0.11%
|
Innoviva Inc
|
INVA |
0.11%
|
Harrow Inc
|
HROW |
0.11%
|
ArriVent Biopharma Inc
|
AVBP |
0.11%
|
Novavax Inc
|
NVAX |
0.1%
|
Personalis Inc
|
PSNL |
0.1%
|
Inhibrx Biosciences Inc
|
INBX |
0.1%
|
Xeris Biopharma Holdings Inc
|
XERS |
0.1%
|
Immunocore Holdings PLC
|
IMCR |
0.1%
|
Corvus Pharmaceuticals Inc
|
CRVS |
0.09%
|
Ardelyx Inc
|
ARDX |
0.09%
|
MeiraGTx Holdings plc
|
MGTX |
0.09%
|
Savara Inc
|
SVRA |
0.09%
|
MannKind Corp
|
MNKD |
0.09%
|
EyePoint Inc
|
EYPT |
0.08%
|
WaVe Life Sciences Ltd
|
WaVe.Life.Sciences.Ltd |
0.08%
|
Xencor Inc
|
XNCR |
0.08%
|
Collegium Pharmaceutical Inc
|
COLL |
0.08%
|
ORIC Pharmaceuticals Inc
|
ORIC |
0.08%
|
First Tracks Biotherapeutics Inc
|
TRAX |
0.08%
|
Cullinan Therapeutics Inc
|
CGEM |
0.08%
|
BioAge Labs Inc
|
BIOA |
0.07%
|
Solid Biosciences Inc
|
SLDB |
0.07%
|
Sana Biotechnology Inc
|
SANA |
0.07%
|
Olema Pharmaceuticals Inc
|
OLMA |
0.07%
|
Kura Oncology Inc
|
KURA |
0.07%
|
Vor BioPharma Inc
|
VOR |
0.07%
|
Alvotech SA
|
ALVO |
0.07%
|
Eton Pharmaceuticals Inc
|
ETON |
0.07%
|
Janux Therapeutics Inc
|
JANX |
0.07%
|
Arbutus Biopharma Corp
|
ABUS |
0.07%
|
Pacira BioSciences Inc
|
PCRX |
0.07%
|
Geron Corp
|
GERN |
0.07%
|
Annexon Inc
|
ANNX |
0.07%
|
Phathom Pharmaceuticals Inc
|
PHAT |
0.07%
|
Design Therapeutics Inc
|
DSGN |
0.06%
|
Replimune Group Inc
|
REPL |
0.06%
|
Grifols SA
|
GRFS |
0.06%
|
Maravai LifeSciences Holdings Inc
|
MRVI |
0.06%
|
Theravance Biopharma Inc
|
TBPH |
0.06%
|
CytomX Therapeutics Inc
|
CTMX |
0.06%
|
Amphastar Pharmaceuticals Inc
|
AMPH |
0.06%
|
Zevra Therapeutics Inc
|
ZVRA |
0.06%
|
Esperion Therapeutics Inc
|
ESPR |
0.06%
|
Rigel Pharmaceuticals Inc
|
RIGL |
0.05%
|
REGENXBIO Inc
|
RGNX |
0.05%
|
Aclaris Therapeutics Inc
|
ACRS |
0.05%
|
ARS Pharmaceuticals Inc
|
SPRY |
0.05%
|
Mesoblast Ltd
|
MESO |
0.05%
|
Ironwood Pharmaceuticals Inc
|
IRWD |
0.05%
|
Prime Medicine Inc
|
PRME |
0.05%
|
Castle Biosciences Inc
|
CSTL |
0.05%
|
Omeros Corp
|
OMER |
0.05%
|
Allogene Therapeutics Inc
|
ALLO |
0.05%
|
Candel Therapeutics Inc
|
CADL |
0.05%
|
Aura Biosciences Inc
|
AURA |
0.05%
|
Invesco Government & Agency Portfolio
|
Invesco.Government...Agency.Portfolio |
0.05%
|
Phibro Animal Health Corp
|
PAHC |
0.05%
|
CorMedix Inc
|
CRMD |
0.05%
|
Neurogene Inc
|
NGNE |
0.05%
|
4D Molecular Therapeutics Inc
|
FDMT |
0.05%
|
Tectonic Therapeutic Inc
|
TECX |
0.04%
|
Zai Lab Ltd
|
ZLAB |
0.04%
|
Altimmune Inc
|
ALT |
0.04%
|
Kyverna Therapeutics Inc
|
KYTX |
0.04%
|
Arvinas Inc
|
ARVN |
0.04%
|
Aquestive Therapeutics Inc
|
AQST |
0.04%
|
Cabaletta Bio Inc
|
CABA |
0.03%
|
Editas Medicine Inc
|
EDIT |
0.03%
|
Contineum Therapeutics Inc
|
CTNM |
0.03%
|
Prothena Corp PLC
|
Prothena.Corp.PLC |
0.03%
|
Pacific Biosciences of California Inc
|
PACB |
0.03%
|
C4 Therapeutics Inc
|
CCCC |
0.03%
|
Silence Therapeutics PLC
|
SLN |
0.03%
|
Lakefront Biotherapeutics NV
|
LKFT |
0.03%
|
Rocket Pharmaceuticals Inc
|
RCKT |
0.03%
|
Evolus Inc
|
EOLS |
0.03%
|
Sagimet Biosciences Inc
|
SGMT |
0.03%
|
Larimar Therapeutics Inc
|
LRMR |
0.03%
|
Upstream Bio Inc
|
UPB |
0.03%
|
Enanta Pharmaceuticals Inc
|
ENTA |
0.03%
|
Kamada Ltd
|
KMDA |
0.03%
|
Puma Biotechnology Inc
|
PBYI |
0.03%
|
Lexeo Therapeutics Inc
|
LXEO |
0.03%
|
Atea Pharmaceuticals Inc
|
AVIR |
0.03%
|
Vanda Pharmaceuticals Inc
|
VNDA |
0.03%
|
Lyell Immunopharma Inc
|
LYEL |
0.02%
|
Foghorn Therapeutics Inc
|
FHTX |
0.02%
|
Immuneering Corp
|
IMRX |
0.02%
|
Autolus Therapeutics PLC
|
AUTL |
0.02%
|
OmniAb Inc
|
OABI |
0.02%
|
Neumora Therapeutics Inc
|
NMRA |
0.02%
|
Alpha Teknova Inc
|
TKNO |
0.02%
|
Entrada Therapeutics Inc
|
TRDA |
0.02%
|
AC Immune SA
|
ACIU |
0.02%
|
Coherus Oncology Inc
|
CHRS |
0.02%
|
SIGA Technologies Inc
|
SIGA |
0.02%
|
Anavex Life Sciences Corp
|
AVXL |
0.02%
|
Fulcrum Therapeutics Inc
|
FULC |
0.02%
|
Keros Therapeutics Inc
|
KROS |
0.02%
|
Invivyd Inc
|
ADGI |
0.02%
|
Orchestra BioMed Holdings Inc
|
OBIO |
0.02%
|
Codexis Inc
|
CDXS |
0.02%
|
Voyager Therapeutics Inc
|
VYGR |
0.01%
|
NovaBridge Biosciences
|
IMAB |
0.01%
|
Arcturus Therapeutics Holdings Inc
|
ARCT |
0.01%
|
Bicycle Therapeutics PLC
|
BCYC |
0.01%
|
Caribou Biosciences Inc
|
CRBU |
0.01%
|
Quantum-Si Inc
|
QSI |
0.01%
|
Tenaya Therapeutics Inc
|
TNYA |
0.01%
|
LENZ Therapeutics Inc
|
LENZ |
0.01%
|
Lifecore Biomedical Inc
|
LNDC |
0.01%
|
Jyong Biotech Ltd
|
MENS |
0.01%
|
CASH & EQUIVALENTS
|
CASH...EQUIVALENTS |
0.01%
|
Pyxis Oncology Inc
|
PYXS |
0.01%
|
PepGen Inc
|
PEPG |
0.01%
|
Humacyte Inc
|
HUMA |
0.01%
|
Aardvark Therapeutics Inc
|
AARD |
0.01%
|
Black Diamond Therapeutics Inc
|
BDTX |
0.01%
|
Rani Therapeutics Holdings Inc
|
RANI |
0.01%
|
Gossamer Bio Inc
|
GOSS |
0%
|
Cartesian Therapeutics Inc 12/31/2050
|
Cartesian.Therapeutics.Inc.12.31.2050 |
0%
|
SECURITIES LENDING - BNYM
|
SECURITIES.LENDING...BNYM |
0%
|
Third Harmonic Bio Inc
|
THRD |
0%
|
Eli Lilly & Co
|
Eli.Lilly...Co |
0%
|
OmniAb Inc 11/02/2027
|
OmniAb.Inc.11.02.2027 |
0%
|
OmniAb Inc 11/02/2027
|
OmniAb.Inc.11.02.2027 |
0%
|
Novo Nordisk A/S
|
Novo.Nordisk.A.S |
0%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
Invesco Nasdaq Biotechnology ETF (IBBQ) share price today is $33.09.
Yes, Indians can buy shares of Invesco Nasdaq Biotechnology ETF (IBBQ) on Vested. To buy IBBQ from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Invesco Nasdaq Biotechnology ETF (IBBQ) on Vested. You can start investing in Invesco Nasdaq Biotechnology ETF (IBBQ) with a minimum investment of $1.
The 52-week high price of Invesco Nasdaq Biotechnology ETF (IBBQ) is $34.2. The 52-week low price of Invesco Nasdaq Biotechnology ETF (IBBQ) is $21.58.
The stock symbol (or ticker) of Invesco Nasdaq Biotechnology ETF is IBBQ.
Yes, you can setup SIP in Invesco Nasdaq Biotechnology ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of IBBQ on the Vested app.
The expense ratio of Invesco Nasdaq Biotechnology ETF (IBBQ) is 0.19%.
Link copied